Nonsurgical treatment for upper eyelid retraction in patients with inactive Graves’ orbitopathy

PURPOSE: To evaluate the effectiveness of incobotulinumtoxinA (Xeomin(®)) in treating upper eyelid retraction in patients with Graves orbitopathy (GO) initially scheduled for surgery via two different application sites. METHODS: This is a comparative, prospective study, conducted at the Department o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vokurka Topljak, Sandra, Galiot Delić, Martina, Mandić, Krešimir, Perić, Sanja, Baretić, Maja, Juri Mandić, Jelena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805617/
https://www.ncbi.nlm.nih.gov/pubmed/36587368
http://dx.doi.org/10.1007/s10792-022-02625-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805617/
https://www.ncbi.nlm.nih.gov/pubmed/36587368
http://dx.doi.org/10.1007/s10792-022-02625-7

Ejemplares similares